163 related articles for article (PubMed ID: 23593186)
1. Differentiation of central lung cancer from atelectasis: comparison of diffusion-weighted MRI with PET/CT.
Yang RM; Li L; Wei XH; Guo YM; Huang YH; Lai LS; Chen AM; Liu GS; Xiong WF; Luo LP; Jiang XQ
PLoS One; 2013; 8(4):e60279. PubMed ID: 23593186
[TBL] [Abstract][Full Text] [Related]
2. Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study.
Qi LP; Zhang XP; Tang L; Li J; Sun YS; Zhu GY
Eur Radiol; 2009 Feb; 19(2):333-41. PubMed ID: 18690450
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
[TBL] [Abstract][Full Text] [Related]
4. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT.
Ohno Y; Koyama H; Yoshikawa T; Nishio M; Aoyama N; Onishi Y; Takenaka D; Matsumoto S; Maniwa Y; Nishio W; Nishimura Y; Itoh T; Sugimura K
Radiology; 2011 Nov; 261(2):605-15. PubMed ID: 21926377
[TBL] [Abstract][Full Text] [Related]
5. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
6. Preliminary comparison of diffusion-weighted MRI and PET/CT in predicting histological type and malignancy of lung cancer.
Liu LP; Zhang XX; Cui LB; Li J; Yang JL; Yang HN; Zhang Y; Zhou Y; Tang X; Qi S; Fang Y; Zhang J; Yin H
Clin Respir J; 2017 Mar; 11(2):151-158. PubMed ID: 25918835
[TBL] [Abstract][Full Text] [Related]
7. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
[TBL] [Abstract][Full Text] [Related]
8. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
9. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.
Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Kassai Y; Yui M; Matsumoto S; Sugimura K
Eur J Radiol; 2015 Nov; 84(11):2321-31. PubMed ID: 26231045
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
[TBL] [Abstract][Full Text] [Related]
12. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging.
Song I; Kim SH; Lee SJ; Choi JY; Kim MJ; Rhim H
Br J Radiol; 2012 May; 85(1013):577-86. PubMed ID: 21343320
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma.
Baysal T; Mutlu DY; Yologlu S
Magn Reson Imaging; 2009 Dec; 27(10):1447-54. PubMed ID: 19553048
[TBL] [Abstract][Full Text] [Related]
14. Lung carcinoma: diffusion-weighted mr imaging--preliminary evaluation with apparent diffusion coefficient.
Matoba M; Tonami H; Kondou T; Yokota H; Higashi K; Toga H; Sakuma T
Radiology; 2007 May; 243(2):570-7. PubMed ID: 17400757
[TBL] [Abstract][Full Text] [Related]
15. DW MRI at 3.0 T versus FDG PET/CT for detection of malignant pulmonary tumors.
Zhang J; Cui LB; Tang X; Ren XL; Shi JR; Yang HN; Zhang Y; Li ZK; Wu CG; Jian W; Zhao F; Ti XY; Yin H
Int J Cancer; 2014 Feb; 134(3):606-11. PubMed ID: 23893610
[TBL] [Abstract][Full Text] [Related]
16. Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging--initial experience.
Coolen J; De Keyzer F; Nafteux P; De Wever W; Dooms C; Vansteenkiste J; Roebben I; Verbeken E; De Leyn P; Van Raemdonck D; Nackaerts K; Dymarkowski S; Verschakelen J
Radiology; 2012 Jun; 263(3):884-92. PubMed ID: 22535562
[TBL] [Abstract][Full Text] [Related]
17. No correlation between glucose metabolism and apparent diffusion coefficient in diffuse large B-cell lymphoma: a PET/CT and DW-MRI study.
Wu X; Korkola P; Pertovaara H; Eskola H; Järvenpää R; Kellokumpu-Lehtinen PL
Eur J Radiol; 2011 Aug; 79(2):e117-21. PubMed ID: 21596501
[TBL] [Abstract][Full Text] [Related]
18. Functional imaging with diffusion-weighted MRI for lung biopsy planning: initial experience.
Guimaraes MD; Marchiori E; Odisio BC; Hochhegger B; Bitencourt AG; Zurstrassen CE; Tyng CC; Gross JL; Chojniak R; Godoy MC
World J Surg Oncol; 2014 Jul; 12():203. PubMed ID: 25012544
[TBL] [Abstract][Full Text] [Related]
19. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.
Sommer G; Wiese M; Winter L; Lenz C; Klarhöfer M; Forrer F; Lardinois D; Bremerich J
Eur Radiol; 2012 Dec; 22(12):2859-67. PubMed ID: 22772365
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma--a pilot study: comparison with 2-deoxy-2-fluoro- D-glucose-positron emission tomography/computed tomography.
Wu X; Kellokumpu-Lehtinen PL; Pertovaara H; Korkola P; Soimakallio S; Eskola H; Dastidar P
NMR Biomed; 2011 Dec; 24(10):1181-90. PubMed ID: 21387451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]